Why PEPFAR's top scientist stepped down

Mike Reid, the former chief science officer of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), resigned amid growing concerns over the direction of America’s global health strategy. Reid cited a fundamental conflict between the U.S. government’s foreign policy objectives and its global health commitments, particularly the increasing tendency to tie lifesaving health aid to broader commercial and geopolitical agreements. He expressed alarm that access to essential HIV treatments and prevention services might be withheld if the U.S. does not secure economic or strategic benefits, such as mineral rights, from partner countries. Reid’s departure highlights tensions within U.S. foreign aid policy, especially following recent shifts under the Trump administration that restructured aid delivery by dismantling USAID and favoring direct bilateral agreements. These changes risk undermining long-standing health programs by prioritizing American commercial interests over equitable access to care. Reid emphasized that while global health initiatives have traditionally served as instruments of soft power, the new approach could jeopardize the health outcomes of vulnerable populations, particularly marginalized communities disproportionately affected by HIV. Recent PEPFAR data from 2024 reveals a troubling decline in HIV testing and prevention services, although treatment retention remains relatively stable in many countries. Reid and other global health experts worry that these declines could reverse progress made over two decades in controlling the epidemic. The uneven reduction in services threatens to widen health disparities, as marginalized groups face greater barriers to care. Reid’s resignation serves as a cautionary signal about the potential consequences of intertwining health aid with geopolitical and economic agendas, raising critical questions about the moral and practical imperatives of U.S. involvement in global health. The situation underscores the importance of maintaining a clear separation between humanitarian health goals and foreign policy interests to ensure that lifesaving treatments remain accessible to those in need. Reid’s exit from PEPFAR draws attention to the broader debate over the future of U.S. global health leadership and the ethical responsibilities that come with it.